Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Open Access
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. 4 (1), 31-38
- https://doi.org/10.2147/vhrm.2008.04.01.31
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 65 references indexed in Scilit:
- Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trialsCatheterization and Cardiovascular Interventions, 2007
- Treatment of restenosis with a paclitaxel-coated balloon catheter.2007
- Compliance of a cobalt chromium coronary stent alloy – the COVIS trialCurrent Controlled Trials in Cardiovascular Medicine, 2005
- First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.2005
- Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trialsInternational Journal of Cardiology, 2005
- Rapamycin Analogs for Stent-Based Local Drug DeliveryHerz, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 2004
- Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.2003
- Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)Journal of the American College of Cardiology, 2002
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseThe New England Journal of Medicine, 1994